These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

157 related items for PubMed ID: 14508048

  • 1. Cutaneous vasculitis associated with rofecoxib.
    Lillicrap MS, Merry P.
    Rheumatology (Oxford); 2003 Oct; 42(10):1267-8. PubMed ID: 14508048
    [No Abstract] [Full Text] [Related]

  • 2. [Rofecoxib-related cutaneous vasculitis].
    Defuentes G, Lecoules S, Coutant G, Algayres JP.
    Presse Med; 2005 Aug 27; 34(14):1007-8. PubMed ID: 16225254
    [Abstract] [Full Text] [Related]

  • 3. Bortezomib-associated cutaneous vasculitis.
    Garcia-Navarro X, Puig L, Fernández-Figueras MT, Dalmau J, Roe E, Alomar A.
    Br J Dermatol; 2007 Oct 27; 157(4):799-801. PubMed ID: 17635511
    [No Abstract] [Full Text] [Related]

  • 4. Rofecoxib-induced pseudoporphyria.
    Markus R, Reddick ME, Rubenstein MC.
    J Am Acad Dermatol; 2004 Apr 27; 50(4):647-8. PubMed ID: 15034522
    [No Abstract] [Full Text] [Related]

  • 5. Leflunomide induced vasculitis--a dose-response relationship.
    Chan AT, Bradlow A, McNally J.
    Rheumatology (Oxford); 2003 Mar 27; 42(3):492-3. PubMed ID: 12626811
    [No Abstract] [Full Text] [Related]

  • 6. Allergic vasculitis associated with celecoxib.
    Jordan KM, Edwards CJ, Arden NK.
    Rheumatology (Oxford); 2002 Dec 27; 41(12):1453-5. PubMed ID: 12468830
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Psoriasis associated with rofecoxib.
    Clark DW, Coulter DM.
    Arch Dermatol; 2003 Sep 27; 139(9):1223. PubMed ID: 12975177
    [No Abstract] [Full Text] [Related]

  • 12. Adalimumab causing vasculitis.
    Orpin SD, Majmudar VB, Soon C, Azam NA, Salim A.
    Br J Dermatol; 2006 May 27; 154(5):998-9. PubMed ID: 16634911
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Cutaneous vasculitis induced by cyclo-oxygenase-2 selective inhibitors.
    Drago F, Brusati C, Desirello G, Cacciapuoti M, Rebora A.
    J Am Acad Dermatol; 2004 Dec 27; 51(6):1029-30. PubMed ID: 15583611
    [No Abstract] [Full Text] [Related]

  • 16. Rofecoxib-associated upper gastrointestinal bleed: a case report.
    Freedman GM, Kreitzer JM, Badola R.
    Mt Sinai J Med; 2002 Dec 27; 69(1-2):105-6. PubMed ID: 11832981
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Rofecoxib and inflammatory bowel disease: clinical and pathologic observations.
    Wilcox GM, Mattia AR.
    J Clin Gastroenterol; 2005 Feb 27; 39(2):142-3. PubMed ID: 15681911
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Naproxen-induced generalized bullous fixed drug eruption.
    Bandino JP, Wohltmann WE, Bray DW, Hoover AZ.
    Dermatol Online J; 2009 Nov 15; 15(11):4. PubMed ID: 19951640
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.